Your browser doesn't support javascript.
loading
FGFR Signaling as a Candidate Therapeutic Target for Cancers Resistant to Carbon Ion Radiotherapy.
Darwis, Narisa Dewi Maulany; Nachankar, Ankita; Sasaki, Yasushi; Matsui, Toshiaki; Noda, Shin-Ei; Murata, Kazutoshi; Tamaki, Tomoaki; Ando, Ken; Okonogi, Noriyuki; Shiba, Shintaro; Irie, Daisuke; Kaminuma, Takuya; Kumazawa, Takuya; Anakura, Mai; Yamashita, Souichi; Hirakawa, Takashi; Kakoti, Sangeeta; Hirota, Yuka; Tokino, Takashi; Iwase, Akira; Ohno, Tatsuya; Shibata, Atsushi; Oike, Takahiro; Nakano, Takashi.
Afiliación
  • Darwis NDM; Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan. narisajimmy@gmail.com.
  • Nachankar A; Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan. drankitan@gmail.com.
  • Sasaki Y; Department of Medical Genome Sciences, Research Institute for Frontier Medicine, Sapporo Medical University, Sapporo 060-8556, Japan. yasushi@sapmed.ac.jp.
  • Matsui T; Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan. matsu.toshi42@gmail.com.
  • Noda SE; Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan. nodashin@saitama-med.ac.jp.
  • Murata K; Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan. kazutoshi.m@gmail.com.
  • Tamaki T; Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan. tamakit@fmu.ac.jp.
  • Ando K; Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan. ken.ando0906@gmail.com.
  • Okonogi N; Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan. okonogi.noriyuki@qst.go.jp.
  • Shiba S; Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan. shiba4885@yahoo.co.jp.
  • Irie D; Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan. daisuke.i0626@gmail.com.
  • Kaminuma T; Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan. cami_taku@yahoo.co.jp.
  • Kumazawa T; Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan. takuya.kumazawa@gmail.com.
  • Anakura M; Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan. mai.anakura@gmail.com.
  • Yamashita S; Department of Obstetrics and Gynecology, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan. soichi-y@gunma-cc.jp.
  • Hirakawa T; Department of Obstetrics and Gynecology, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan. tahirakawa@gmail.com.
  • Kakoti S; Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan. drsangeeta84@gmail.com.
  • Hirota Y; Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan. yukahirota@gunma-u.ac.jp.
  • Tokino T; Department of Medical Genome Sciences, Research Institute for Frontier Medicine, Sapporo Medical University, Sapporo 060-8556, Japan. tokino@sapmed.ac.jp.
  • Iwase A; Department of Obstetrics and Gynecology, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan. akiwase@gunma-u.ac.jp.
  • Ohno T; Gunma University Heavy Ion Medical Center, Maebashi 371-8511, Japan. tohno@gunma-u.ac.jp.
  • Shibata A; Gunma University Initiative for Advanced Research (GIAR), Maebashi 371-8511, Japan. shibata.at@gunma-u.ac.jp.
  • Oike T; Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan. oiketakahiro@gmail.com.
  • Nakano T; Gunma University Heavy Ion Medical Center, Maebashi 371-8511, Japan. oiketakahiro@gmail.com.
Int J Mol Sci ; 20(18)2019 Sep 14.
Article en En | MEDLINE | ID: mdl-31540114

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptor Tipo 3 de Factor de Crecimiento de Fibroblastos / Receptor Tipo 4 de Factor de Crecimiento de Fibroblastos / Radioterapia de Iones Pesados / Recurrencia Local de Neoplasia Tipo de estudio: Prognostic_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Int J Mol Sci Año: 2019 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptor Tipo 3 de Factor de Crecimiento de Fibroblastos / Receptor Tipo 4 de Factor de Crecimiento de Fibroblastos / Radioterapia de Iones Pesados / Recurrencia Local de Neoplasia Tipo de estudio: Prognostic_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Int J Mol Sci Año: 2019 Tipo del documento: Article País de afiliación: Japón